September is Thyroid Cancer Awareness Month and Dr. Amanda Laird, Chief of Endocrine Surgery at Rutgers Cancer Institute of New Jersey shares information on types of thyroid cancer, how it is diagnosed and treatment options.
In what is believed to be the largest dataset study to date examining the role of race on survival outcome for pediatric patients with Hodgkin lymphoma, investigators at Rutgers Cancer Institute of New Jersey have found that black patients have significantly worse overall survival at five years than white patients when accounting for all available clinical variables.
From maintaining regular check-ups and keeping up to date with recommended vaccinations to a good diet and exercise, some simple tips can help keep youngsters healthy as they head back to class - and are cancer preventive too.
An estimated 61,780 new cases of leukemia will be diagnosed in the United States this year. Although leukemias are thought to occur in childhood, they can actually present at any age in both children and adults.
A pair of Rutgers Cancer Institute of New Jersey physician-scientists are collaborating on national research projects that received $1.5 million in combined funding from the Oncology Research Information Exchange Network® (ORIEN) New Oncologic Visionary Awards (NOVA) program.
A Rutgers Cancer Institute of New Jersey pediatric hematologist/oncologist has received a $50,000 grant from the Children’s Oncology Group Foundation to help identify new prognostic markers and potential therapeutic targets in pediatric Hodgkin lymphoma.
Several physicians from Rutgers Cancer Institute of New Jersey have been named among ‘New Jersey’s Top Doctors in Cancer Care’ by Castle Connolly Medical Ltd. The listing appeared recently in Jersey’s Best magazine.
More than $2 million in grants recently awarded to a Rutgers Cancer Institute of New Jersey resident researcher will support examination of potential treatment targets for T-cell acute lymphoblastic leukemia (T-ALL).
Anxiety and depression related to childhood cancer survivorship can be challenging for this population. Rutgers Cancer Institute of New Jersey recently educated pediatric cancer survivors about these topics through its Long-term, Information, Treatment Effects and Evaluation Program annual Survivor’s Family Education Night.
Six Flags Great Adventure, RWJBarnabas Health and the Rutgers Cancer Institute of New Jersey have joined forces to fight cancer and celebrate survivorship with the unveiling of Coasters for Cancer - the first roller coaster wrapped in the hand prints of cancer survivors and supporters.
RWJBarnabas Health and Rutgers Cancer Institute of New Jersey, in partnership with New Brunswick Development Corporation announced the development of a new, state-of-the-art, free-standing cancer pavilion in New Brunswick. The initial estimated project cost is $750 million.
Investigators at Rutgers Cancer Institute of New Jersey have developed a computational method that uncovers clinically relevant gene expression patterns in large cohorts of breast cancer patients. This method, which is applicable to the analysis of all cancers, can robustly describe molecular processes that are associated with tumor subtypes and can identify predictive markers of response to treatment or disease recurrence.
Findings from Rutgers Cancer Institute of New Jersey focused on immunotherapy will be featured at the 2019 American Society of Clinical Oncology Annual Meeting being held in Chicago tomorrow through Tuesday.
Investigators at Rutgers Cancer Institute of New Jersey have found that approximately 30 percent of men with localized prostate cancer may have alterations in DNA damage response pathways.
Rutgers Cancer Institute of New Jersey, the state’s only Comprehensive Cancer Center as recognized by the National Cancer Institute (NCI), has been awarded a $15.1 million grant (P30CA072720) as part of its successful 2019 redesignation.
ScreenNJ, a collaborative program led by Rutgers Cancer Institute and funded in part by the New Jersey Department of Health, aims to increase prevention efforts for prevalent cancers thanks to recommendations resulting from a statewide gathering of health care and community leaders.
A cancer diagnosis can have an emotional as well as physical impact on patients, including coping with an uncertain prognosis, making treatment decisions, and learning how to manage treatment effects. A medical library at New Jersey's only NCI-designated Comprehensive Cancer Center is a vital patient resource.
In the search for more effective therapies for breast cancer, researchers from Rutgers Cancer Institute of New Jersey and Rutgers University are targeting opioid receptors to potentially reduce the development and spread of certain breast cancer subtypes.
Fast growing brain tumors known as glioblastoma multiforme often present treatment challenges due to their diverse tumor cell types and their ability to spread into healthy brain tissue. A Rutgers Cancer Institute of New Jersey researcher examines the impact of a novel small molecule inhibitor in the treatment of glioblastoma multiforme, using a patient’s own tumors cells with patient derived organoids.
Phase 1b and phase 2 clinical trials examining pembrolizumab for advanced small cell lung cancer who received two or more lines of prior treatment show anti-tumor activity with durable responses and manageable toxicity. Rutgers Cancer Institute of New Jersey's Dr. Janice Mehnert, an investigator on the work, shares more.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right